Skip to main content
PMC home page
Bacteriological Reviews logoLink to Bacteriological Reviews
. 1974 Dec;38(4):337–355. doi: 10.1128/br.38.4.337-355.1974

The latent herpes simplex virus.

J J Docherty, M Chopan
PMCID: PMC413863  PMID: 4374179

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON W. A., MARGRUDER B., KILBOURNE E. D. Induced reactivation of herpes simplex virus in healed rabbit corneal lesions. Proc Soc Exp Biol Med. 1961 Jul;107:628–632. doi: 10.3181/00379727-107-26709. [DOI] [PubMed] [Google Scholar]
  2. Akerfeldt S., Geijer S., Holubars E., Fuchs G., Brundin M. Prophylactic and therapeutic antiviral effect of human gamma globulin. Biochem Pharmacol. 1972 Feb 15;21(4):503–509. doi: 10.1016/0006-2952(72)90323-1. [DOI] [PubMed] [Google Scholar]
  3. Albert D. M., Rabson A. S. Inhibition of ocular herpes simples infection in rabbits by extracts of Burkitt's lymphoma cell cultures. Proc Soc Exp Biol Med. 1971 Oct;138(1):108–111. doi: 10.3181/00379727-138-35841. [DOI] [PubMed] [Google Scholar]
  4. Anaka N., Kimura S. J. Localization of herpes simplex antigen and virus. In the corneal stroma of experimental herpetic keratitis. Arch Ophthalmol. 1967 Jul;78(1):68–73. doi: 10.1001/archopht.1967.00980030070013. [DOI] [PubMed] [Google Scholar]
  5. Antonelli A., Vignali C. Ricerche sulla localizzazione del virus dell'herpes simplex dopo guarigione delle recidive cutanee. Coltivazione di cellule della zona colpital da eruzione recidivante. Riv Ist Sieroter Ital. 1968 Jan-Feb;43(1):43–51. [PubMed] [Google Scholar]
  6. Aquavella J. V. The treatment of herpetic stromal disease. Eye Ear Nose Throat Mon. 1972 Oct;51(10):374–381. [PubMed] [Google Scholar]
  7. Ashe W. K., Rizzo A. A. Inapparent herpes simplex virus infection in inoculated rabbits. Proc Soc Exp Biol Med. 1967 Apr;124(4):1150–1154. doi: 10.3181/00379727-124-31948. [DOI] [PubMed] [Google Scholar]
  8. Aston D. L., Cohen A., Spindler M. A. Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J. 1972 Nov 25;4(5838):462–465. doi: 10.1136/bmj.4.5838.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Aurelian L. Possible role of Herpesvirus hominis, type 2, in human cervical cancer. Fed Proc. 1972 Nov-Dec;31(6):1651–1659. [PubMed] [Google Scholar]
  10. Aurelian L., Schumann B., Marcus R. L., Davis H. J. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma. Science. 1973 Jul 13;181(4095):161–164. doi: 10.1126/science.181.4095.161. [DOI] [PubMed] [Google Scholar]
  11. Aurelian L., Strandberg J. D., Davis H. J. HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency. Proc Soc Exp Biol Med. 1972 Jun;140(2):404–408. doi: 10.3181/00379727-140-36468. [DOI] [PubMed] [Google Scholar]
  12. Aurelian L., Strandberg J. D., Melendez L. V., Johnson L. A. Herpesvirus type 2 isolated from cervical tumor cells grown in tissue culture. Science. 1971 Nov 12;174(4010):704–707. doi: 10.1126/science.174.4010.704. [DOI] [PubMed] [Google Scholar]
  13. BLACK P. H., ROWE W. P., TURNER H. C., HUEBNER R. J. A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS. Proc Natl Acad Sci U S A. 1963 Dec;50:1148–1156. doi: 10.1073/pnas.50.6.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. BLANK H., BRODY M. W. Recurrent herpes simplex; a psychiatric and laboratory study. Psychosom Med. 1950 Jul-Aug;12(4):254–260. doi: 10.1097/00006842-195007000-00007. [DOI] [PubMed] [Google Scholar]
  15. BUDDINGH G. J., SCHRUM D. I., LANIER J. C., GUIDRY D. J. Studies of the natural history of herpes simplex infections. Pediatrics. 1953 Jun;11(6):595–610. [PubMed] [Google Scholar]
  16. Baringer J. R., Griffith J. F. Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol. 1970 Jan;29(1):89–104. doi: 10.1097/00005072-197001000-00007. [DOI] [PubMed] [Google Scholar]
  17. Baringer J. R., Swoveland P. Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab Invest. 1974 Feb;30(2):230–240. [PubMed] [Google Scholar]
  18. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  19. Barski G., Le François D., Youn J. K. Infection latente double avec SV5 et virus d'herpès en cultures de cellules de hamster. Ann Inst Pasteur (Paris) 1969 Sep;117(3):420–433. [PubMed] [Google Scholar]
  20. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972 Oct 20;178(4058):306–307. doi: 10.1126/science.178.4058.306. [DOI] [PubMed] [Google Scholar]
  21. Bellanti J. A., Guin G. H., Grassi R. M., Olson L. C. Herpes simplex encephalitis: brain biopsy and treatment with 5-iodo-2'-deoxyuridine. J Pediatr. 1968 Feb;72(2):266–275. doi: 10.1016/s0022-3476(68)80323-3. [DOI] [PubMed] [Google Scholar]
  22. Bellows J. G. Molekulares Vorgehen zum Mechanismus und der Behandlung der Herpesvirus-Keratitis. Klin Monbl Augenheilkd. 1969;155(5):696–706. [PubMed] [Google Scholar]
  23. Ben-Porat T., Demarchi J. M., Kaplan A. S. Characterization of defective interfering viral particles present in a population of pseudorabies virions. Virology. 1974 Sep;61(1):29–37. doi: 10.1016/0042-6822(74)90239-6. [DOI] [PubMed] [Google Scholar]
  24. Benda R., Petrovic S., Rychterová V. Transmission of herpesvirus along the trigeminal nerve in rabbits. Acta Virol. 1972 Nov;16(6):459–465. [PubMed] [Google Scholar]
  25. Bienenstock J., Perey D. Y. Immune mechanisms of mucosal resistance. Med Clin North Am. 1972 Mar;56(2):391–402. doi: 10.1016/s0025-7125(16)32403-8. [DOI] [PubMed] [Google Scholar]
  26. Bikbulatov R. M., Bostandzhian M. G., Fadeeva L. L., Stakhanova V. M. Ob esksperimental'nom izuchenii deistviia razlichnykh interferonogenov pri gerpeticheskoi infektsii. Vopr Virusol. 1972 Nov-Dec;17(6):705–708. [PubMed] [Google Scholar]
  27. Bocharov A. F., Lialina M. I., Moisiadi S. A., Shcheglovitova O. N., Bektemirov T. A. Izuchenie antitelo- i interferonoobrazovaniia u bol'nykh khronicheskim retsidiviruiushchim aftoznym stomatitom. Vopr Virusol. 1972 Jan-Feb;17(1):79–84. [PubMed] [Google Scholar]
  28. Bowers R. E. Melkersson's syndrome. Proc R Soc Med. 1972 Dec;65(12):1078–1078. [PMC free article] [PubMed] [Google Scholar]
  29. Brier A. M., Snyderman R., Mergenhagen S. E., Notkins A. L. Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells. Science. 1970 Dec 4;170(3962):1104–1106. doi: 10.1126/science.170.3962.1104. [DOI] [PubMed] [Google Scholar]
  30. Brier A. M., Wohlenberg C., Rosenthal J., Mage M., Notkins A. L. Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3073–3077. doi: 10.1073/pnas.68.12.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bronson D. L., Dreesman G. R., Biswal N., Benyesh-Melnick M. Defective virions of herpes simplex viruses. Intervirology. 1973;1(3):141–153. doi: 10.1159/000148841. [DOI] [PubMed] [Google Scholar]
  32. Brown D. C. Ocular herpes simplex. Invest Ophthalmol. 1971 Mar;10(3):210–215. [PubMed] [Google Scholar]
  33. Burch G. E., Giles T. D. The role of viruses in the production of heart disease. Am J Cardiol. 1972 Feb;29(2):231–240. doi: 10.1016/0002-9149(72)90634-0. [DOI] [PubMed] [Google Scholar]
  34. CARTON C. A. Effect of previous sensory loss on the appearance of herpes simplex following trigeminal sensory root section. J Neurosurg. 1953 Sep;10(5):463–468. doi: 10.3171/jns.1953.10.5.0463. [DOI] [PubMed] [Google Scholar]
  35. CARTON C. A., KILBOURNE E. D. Activation of latent herpes simplex by trigeminal sensory-root section. N Engl J Med. 1952 Jan 31;246(5):172–176. doi: 10.1056/NEJM195201312460503. [DOI] [PubMed] [Google Scholar]
  36. Catalano L. W., Jr, Goldman J. M. Antibody to Herpesvirus hominis types 1 and 2 in patients with Hodgkin's disease and carcinoma of the nasopharynx. Cancer. 1972 Mar;29(3):597–602. doi: 10.1002/1097-0142(197203)29:3<597::aid-cncr2820290311>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  37. Catalano L. W., Jr Herpesvirus hominis antibody in multiple sclerosis and amyotrophic lateral sclerosis. Neurology. 1972 May;22(5):473–478. doi: 10.1212/wnl.22.5.473. [DOI] [PubMed] [Google Scholar]
  38. Catalano L. W., Jr, London W. T., Rice J. M., Sever J. L. Prophylactic and therapeutic use of poly(I)-poly(C) (poly-D-lysine) against herpesvirus encephalitis in mice. Proc Soc Exp Biol Med. 1972 May;140(1):66–71. doi: 10.3181/00379727-140-36396. [DOI] [PubMed] [Google Scholar]
  39. Centifanto Y. M., Drylie D. M., Deardourff S. L., Kaufman H. E. Herpesvirus type 2 in the male genitourinary tract. Science. 1972 Oct 20;178(4058):318–319. doi: 10.1126/science.178.4058.318. [DOI] [PubMed] [Google Scholar]
  40. Centifanto Y. M., Hildebrandt R. J., Held B., Kaufman H. E. Relationship of herpes simplex genital infection and carcinoma of the cervix: population studies. Am J Obstet Gynecol. 1971 Jul 1;110(5):690–692. doi: 10.1016/0002-9378(71)90255-9. [DOI] [PubMed] [Google Scholar]
  41. Ch'ien L. T., Cannon N. J., Charamella L. J., Dismukes W. E., Whitley R. J., Buchanan R. A., Alford C. A., Jr Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov;128(5):658–663. doi: 10.1093/infdis/128.5.658. [DOI] [PubMed] [Google Scholar]
  42. Chang T. W. Recurrent viral infection (reinfection). N Engl J Med. 1971 Apr 8;284(14):765–773. doi: 10.1056/NEJM197104082841406. [DOI] [PubMed] [Google Scholar]
  43. Charnock E. L., Cramblett H. G. 5-iodo-2'-deoxyuridine in neonatal herpesvirus hominis encephalitis. J Pediatr. 1970 Mar;76(3):459–463. doi: 10.1016/s0022-3476(70)80491-7. [DOI] [PubMed] [Google Scholar]
  44. Cho C. T., Liu C., Voth D. W., Feng K. K. Effects of idoxuridine on Herpesvirus hominis encephalitis and disseminated infections in marmosets. J Infect Dis. 1973 Dec;128(6):718–723. doi: 10.1093/infdis/128.6.718. [DOI] [PubMed] [Google Scholar]
  45. Collard W., Thornton H., Green M. Cells transformed by human Herpesvirus type 2 transcribe virus-specific RNA sequences shared by Herpesvirus types 1 and 2. Nat New Biol. 1973 Jun 27;243(130):264–266. doi: 10.1038/newbio243264a0. [DOI] [PubMed] [Google Scholar]
  46. Croce C. M., Girardi A. J., Koprowski H. Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3617–3620. doi: 10.1073/pnas.70.12.3617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Crouch N. A., Rapp F. Cell-dependent differences in the production of infectious herpes simplex virus at a supraoptimal temperature. J Virol. 1972 Feb;9(2):223–230. doi: 10.1128/jvi.9.2.223-230.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Crouch N. A., Rapp F. Differential effect of temperature on the replication of herpes simplex virus type 1 and type 2. Virology. 1972 Dec;50(3):939–941. doi: 10.1016/0042-6822(72)90452-7. [DOI] [PubMed] [Google Scholar]
  49. Daniel P. Profil virologique de la sclérose en plaques. Etude des anticorps viraux fixant le complément. Nouv Presse Med. 1972 Jul 22;1(29):1939–1942. [PubMed] [Google Scholar]
  50. Daniel R., Karseras A. Assessment of possible potentiating action of ultraviolet light on 5 iodo-2' deoxyuridine in superficial herpetic keratitis. Br J Ophthalmol. 1972 Aug;56(8):604–608. doi: 10.1136/bjo.56.8.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Darai G., Munk K. Human embryonic lung cells abortively infected with Herpes virus hominis type 2 show some properties of cell transformation. Nat New Biol. 1973 Feb 28;241(113):268–269. doi: 10.1038/newbio241268a0. [DOI] [PubMed] [Google Scholar]
  52. Davis D. B., Munyon W., Buchsbaum R., Chawda R. Virus type-specific thymidine kinase in cells biochemically transformed by herpes simplex virus types 1 and 2. J Virol. 1974 Jan;13(1):140–145. doi: 10.1128/jvi.13.1.140-145.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Dawson C., Togni B., Moore T. E., Jr, Coleman V. Herpesvirus infection of human mesodermal tissue (cornea) detected by electron microscopy. Nature. 1968 Feb 3;217(5127):460–462. doi: 10.1038/217460b0. [DOI] [PubMed] [Google Scholar]
  54. Dawson C., Togni B., Moore T. E., Jr Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. Arch Ophthalmol. 1968 Jun;79(6):740–747. doi: 10.1001/archopht.1968.03850040742016. [DOI] [PubMed] [Google Scholar]
  55. DeVoe A. G. The practical management of ocular infections. II. Viral infections. Can J Ophthalmol. 1972 Jan;7(1):13–18. [PubMed] [Google Scholar]
  56. Degos R., Blanchet P., Rain J. D., Reboul D. Herpès cutané chronique au cours d'une hémopathie lymphoïde traitée par chimiothérapie et corticoïdes. Bull Soc Fr Dermatol Syphiligr. 1971;78(6):631–632. [PubMed] [Google Scholar]
  57. Dent P. B., Larke R. P. Viral infection and immunity. Med Clin North Am. 1972 Mar;56(2):353–370. doi: 10.1016/s0025-7125(16)32401-4. [DOI] [PubMed] [Google Scholar]
  58. Dillard S. H., Cheatham W. J., Moses H. L. Electron microscopy of zosteriform herpes simplex infection in the mouse. Lab Invest. 1972 Apr;26(4):391–402. [PubMed] [Google Scholar]
  59. Dodge P. R. Treatment of herpes simplex encephalitis with an antiviral agent. Dev Med Child Neurol. 1968 Oct;10(5):665–666. doi: 10.1111/j.1469-8749.1968.tb02955.x. [DOI] [PubMed] [Google Scholar]
  60. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  61. Duff R., Rapp F. Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol. 1973 Aug;12(2):209–217. doi: 10.1128/jvi.12.2.209-217.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Duff R., Rapp F. Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol. 1971 Oct;8(4):469–477. doi: 10.1128/jvi.8.4.469-477.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. EYRES T. E., PIRTLE E. C. Vaccinia virus immunization of patients with recurrent herpes simplex virus infections. J Lancet. 1958 Dec;78(12):501–504. [PubMed] [Google Scholar]
  64. Ennis F. A. Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun. 1973 Jun;7(6):898–904. doi: 10.1128/iai.7.6.898-904.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Enquist R. W., Ray C. G., Birchfield R. I. Herpes simplex infection of the central nervous system. Survival without IUDR therapy. Northwest Med. 1971 Jun;70(6):420–422. [PubMed] [Google Scholar]
  66. Epstein L. B., Cline M. J., Merigan T. C. The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon. J Clin Invest. 1971 Apr;50(4):744–753. doi: 10.1172/JCI106545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. FREDERICQ P. Localisation du prophage sur le chromosome; son intervention dans le taux de ségrégation apparent des rocombinants d'Escherichia coli K. 12. C R Seances Soc Biol Fil. 1954 Aug-Sep;148(15-18):1501–1504. [PubMed] [Google Scholar]
  68. Farris W. A., Blaw M. E. Cytarabine treatment of herpes simplex encephalitis. Arch Neurol. 1972 Aug;27(2):99–102. doi: 10.1001/archneur.1972.00490140003002. [DOI] [PubMed] [Google Scholar]
  69. Feldman L. A., Sheppard R. D., Bornstein M. B. Herpes simplex virus-host cell relationships in organized cultures of mammalian nerve tissues. J Virol. 1968 Jun;2(6):621–628. doi: 10.1128/jvi.2.6.621-628.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Feorino P., Palmer E. L., Martin M. L. Incidence of herpesvirus antibody among leukemic and nasopharyngeal carcinoma patients. Proc Soc Exp Biol Med. 1972 Mar;139(3):913–915. doi: 10.3181/00379727-139-36265. [DOI] [PubMed] [Google Scholar]
  71. Fiala M., Chow A., Guze L. B. Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains. Antimicrob Agents Chemother. 1972 Apr;1(4):354–357. doi: 10.1128/aac.1.4.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Fishman M. A., Haymond M. W., Middelkamp J. N. Failure of idoxuridine treatment in herpes simplex encephalitis. Am J Dis Child. 1971 Sep;122(3):250–252. doi: 10.1001/archpedi.1971.02110030108017. [DOI] [PubMed] [Google Scholar]
  73. Frenkel N., Roizman B., Cassai E., Nahmias A. A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3784–3789. doi: 10.1073/pnas.69.12.3784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Friedrich E. G., Jr Relief for Herpes vulvitis. Obstet Gynecol. 1973 Jan;41(1):74–77. [PubMed] [Google Scholar]
  75. Fulhorst H. W., Richards A. B., Bowbyes J., Jones B. R. Cryotherapy of epithelial herpes simplex keratitis. Am J Ophthalmol. 1972 Jan;73(1):46–51. doi: 10.1016/0002-9394(72)90303-0. [DOI] [PubMed] [Google Scholar]
  76. Georges J. C., de Lavergne E., Foliguet J. M., Bertrand F., Raspiller A. Etude des réactions immunitaires au cours de l'infection herpétique récurrente chez l'homme. Nouveaux aspects sur l'importance des déficits humoraux. Rev Immunol (Paris) 1970 Oct-Dec;34(6):309–318. [PubMed] [Google Scholar]
  77. Germanov A. B., Sokolov M. I., Vorontsova T. V. Vliianie tipa kletochnoi kul'tury na reproduktsiiu virusa Gerpesa pri povyshennoi temperature. Vopr Virusol. 1972 Jan-Feb;17(1):114–115. [PubMed] [Google Scholar]
  78. Gilbert D. N., Johnson M. T., Luby J. P., Sanford J. P. Herpesvirus hominis type I encephalitis treated with cytarabine, an unresolved problem in encephalitis. Medicine (Baltimore) 1973 Jul;52(4):331–338. doi: 10.1097/00005792-197307000-00012. [DOI] [PubMed] [Google Scholar]
  79. Gilead Z., Ginsberg H. S. Characterization of a Tumorlike Antigen in Type 12 and Type 18 Adenovirus-Infected Cells. J Bacteriol. 1965 Jul;90(1):120–125. doi: 10.1128/jb.90.1.120-125.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Glasgow L. A. Cellular immunity in host resistance to viral infections. Arch Intern Med. 1970 Jul;126(1):125–134. [PubMed] [Google Scholar]
  81. Gordon H. L., Miller D. H., Rawls W. E. Viral studies in patients with non-specific prostatourethritis. J Urol. 1972 Aug;108(2):299–300. doi: 10.1016/s0022-5347(17)60718-3. [DOI] [PubMed] [Google Scholar]
  82. Gresser I., Lang D. J. Relationships between viruses and leucocytes. Prog Med Virol. 1966;8:62–130. [PubMed] [Google Scholar]
  83. HENLE W. INTERFERENCE AND INTERFERON IN PERSISTENT VIRAL INFECTIONS OF CELL CULTURES. J Immunol. 1963 Aug;91:145–150. [PubMed] [Google Scholar]
  84. HERRIOTT R. M., CONNOLLY J. H., GUPTA S. Blood nucleases and infectious viral nucleic acids. Nature. 1961 Mar 11;189:817–820. doi: 10.1038/189817a0. [DOI] [PubMed] [Google Scholar]
  85. HERRIOTT R. M. Infectious nucleic acids, a new dimension in virology. Science. 1961 Jul 28;134(3474):256–260. doi: 10.1126/science.134.3474.256. [DOI] [PubMed] [Google Scholar]
  86. HOGGAN M. D., ROIZMAN B. The effect of the temperature of incubation on the formation and release of herpes simplex virus in infected FL cells. Virology. 1959 Aug;8:508–524. doi: 10.1016/0042-6822(59)90052-2. [DOI] [PubMed] [Google Scholar]
  87. HUEBNER R. J., ROWE W. P., LANE W. T. Oncogenic effects in hamsters of human adenovirus types 12 and 18. Proc Natl Acad Sci U S A. 1962 Dec 15;48:2051–2058. doi: 10.1073/pnas.48.12.2051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Hable K. A., Washington J. A., 2nd, Herrmann E. C., Jr Bacterial and viral throat flora. Comparison of findings in children with acute upper respiratory tract disease and in healthy controls during winter. Clin Pediatr (Phila) 1971 Apr;10(4):199–203. doi: 10.1177/000992287101000405. [DOI] [PubMed] [Google Scholar]
  89. Hampar B., Burroughs M. A. Mechanism of persistent herpes simplex virus infection in vitro. J Natl Cancer Inst. 1969 Sep;43(3):621–634. [PubMed] [Google Scholar]
  90. Hampar B., Keehn M. A. Cumulative changes in the antigenic properties of herpes simplex virus from persistently infected cell cultures. J Immunol. 1967 Sep;99(3):554–557. [PubMed] [Google Scholar]
  91. Hampar B., Notkins A. L., Mage M., Keehn M. A. Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol. 1968 Mar;100(3):586–593. [PubMed] [Google Scholar]
  92. Harland W. A., Adams J. H., McSeveney D. Herpes-simplex particles in acute necrotising encephalitis. Lancet. 1967 Sep 16;2(7516):581–582. doi: 10.1016/s0140-6736(67)90737-4. [DOI] [PubMed] [Google Scholar]
  93. Herout V., Vortel V., Vondrácková A. Herpes simplex involvement of the lower respiratory tract. Am J Clin Pathol. 1966 Oct;46(4):411–419. doi: 10.1093/ajcp/46.4.411. [DOI] [PubMed] [Google Scholar]
  94. Hervouet F. Conduite à tenir en présence d'une kératite métaherpétique. Ann Ocul (Paris) 1972 Jan;205(1):69–71. [PubMed] [Google Scholar]
  95. Hirai K., Defendi V. Homology between SV40 DNA and DNA of normal and SV40-transformed Chinese hamster cells. Biochem Biophys Res Commun. 1971 Feb 19;42(4):714–722. doi: 10.1016/0006-291x(71)90546-8. [DOI] [PubMed] [Google Scholar]
  96. Hoerni B., Simon G., Chauvergne J. Infection à herpès-virus au cours de la maladie de Hodgkin. Bord Med. 1972 Apr;5(7):771–776. [PubMed] [Google Scholar]
  97. Hollinshead A., Tarro G., Foster W. A., Jr, Seigel L. J., Jaffurs W. Studies of tumor-specific and herpesvirus nonvirion antigens. Cancer Res. 1974 May;34(5):1122–1125. [PubMed] [Google Scholar]
  98. Hryniuk W., Foerster J., Shojania M., Chow A. Cytarabine for herpesvirus infections. JAMA. 1972 Feb;219(6):715–718. [PubMed] [Google Scholar]
  99. Huang A. S., Baltimore D. Defective viral particles and viral disease processes. Nature. 1970 Apr 25;226(5243):325–327. doi: 10.1038/226325a0. [DOI] [PubMed] [Google Scholar]
  100. Huraux J. M., Bricout F., Idatte J. M., Leroux-Robert C., Regnard J., Lagrange P., Kourilsky O., Acar J. Renal transplantation and viral infections. I. A retrospective serological study of renal transplantation recipients. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):670–679. [PubMed] [Google Scholar]
  101. Ito M., Barron A. L. Surface antigen produced by herpes simplex virus (HSV). J Immunol. 1972 Mar;108(3):711–718. [PubMed] [Google Scholar]
  102. JACOB F., WOLLMAN E. L. Les épisomes, éléments génétiques ajoutés. C R Hebd Seances Acad Sci. 1958 Jul 7;247(1):154–156. [PubMed] [Google Scholar]
  103. JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING. J Exp Med. 1964 Feb 1;119:343–356. doi: 10.1084/jem.119.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Johnson K. P., Rosenthal M. S., Lerner P. I. Herpes simplex encephalitis. The course in five virologically proven cases. Arch Neurol. 1972 Aug;27(2):103–108. doi: 10.1001/archneur.1972.00490140007003. [DOI] [PubMed] [Google Scholar]
  105. Johnson R. T. Neurologic diseases associated with viral infections. Postgrad Med. 1971 Sep;50(3):158–163. doi: 10.1080/00325481.1971.11697599. [DOI] [PubMed] [Google Scholar]
  106. Josey W. E., Nahmias A. J., Naib Z. M. The epidemiology of Type 2 (genital) herpes simplex virus infection. Obstet Gynecol Surv. 1972 Apr;27(4):suppl–suppl:302. doi: 10.1097/00006254-197204000-00028. [DOI] [PubMed] [Google Scholar]
  107. Juel-Jensen B. E. Cannabis and recurrent herpes simplex. Br Med J. 1972 Nov 4;4(5835):296–296. doi: 10.1136/bmj.4.5835.296-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Kagan C. Letter: Lysine therapy for herpes simplex. Lancet. 1974 Jan 26;1(7848):137–137. doi: 10.1016/s0140-6736(74)92374-5. [DOI] [PubMed] [Google Scholar]
  109. Kaneko M. [Sensitivity of herpes simplex virus to antiviral and other several drugs]. Nippon Ganka Gakkai Zasshi. 1972 Jul;76(7):399–403. [PubMed] [Google Scholar]
  110. Kasparov A. A., Maevskaia T. M. Opyt diagnosticheskogo i lechibnogo ispol'zovaniia gerpeticheskoŭ polivaktsiny. Oftalmol Zh. 1972;27(2):119–124. [PubMed] [Google Scholar]
  111. Kasparov A. A. Znachenie induktorov interferona v sovremennoi protivovirusnoi terapii gerpeticheskoi bolezni glaz. Vestn Oftalmol. 1972 Mar-Apr;2:63–67. [PubMed] [Google Scholar]
  112. Kaufman H. E., Brown D. C., Ellison E. D. Herpes virus in the lacrimal gland, conjunctiva and cornea of man--a chronic infection. Am J Ophthalmol. 1968 Jan;65(1):32–35. doi: 10.1016/0002-9394(68)91024-6. [DOI] [PubMed] [Google Scholar]
  113. Kaufman H. E., Brown D. C., Ellison E. M. Recurrent herpes in the rabbit and man. Science. 1967 Jun 23;156(3782):1628–1629. doi: 10.1126/science.156.3782.1628. [DOI] [PubMed] [Google Scholar]
  114. Kaufman H. E., Ellison E. D., Centifanto Y. M. Difference in interferon response and protection from ocular virus infection in rabbits and monkeys. Am J Ophthalmol. 1972 Jul;74(1):89–92. doi: 10.1016/0002-9394(72)91131-2. [DOI] [PubMed] [Google Scholar]
  115. Kaufman R. H., Gardner H. L., Brown D., Wallis C., Rawls W. E., Melnick J. L. Herpes genitalis treated by photodynamic inactivation of virus. Am J Obstet Gynecol. 1973 Dec 15;117(8):1144–1146. doi: 10.1016/0002-9378(73)90768-0. [DOI] [PubMed] [Google Scholar]
  116. Kaufman R. H., Rawls W. H. Extragenital type 2 herpesvirus infection. Am J Obstet Gynecol. 1972 Mar 15;112(6):866–867. doi: 10.1016/0002-9378(72)90168-8. [DOI] [PubMed] [Google Scholar]
  117. Kibrick S., Takahashi G. H., Leibowitz H. M., Laibson P. R. Local corticosteroid therapy and reactivation of herpetic keratitis. Arch Ophthalmol. 1971 Dec;86(6):694–698. doi: 10.1001/archopht.1971.01000010696015. [DOI] [PubMed] [Google Scholar]
  118. Kleger B., Prier J. E., Rosato D. J., McGinnis A. E. Herpes simplex infection of the female genital tract. I. Incidence of infection. Am J Obstet Gynecol. 1968 Nov 1;102(5):745–748. doi: 10.1016/0002-9378(68)90388-8. [DOI] [PubMed] [Google Scholar]
  119. Klein G. Herpesviruses and oncogenesis. Proc Natl Acad Sci U S A. 1972 Apr;69(4):1056–1064. doi: 10.1073/pnas.69.4.1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Klein G. Summary of papers delivered at the Conference on Herpesvirus and Cervical Cancer (Key Biscayne, Florida). Cancer Res. 1973 Jun;33(6):1557–1563. [PubMed] [Google Scholar]
  121. Klein R. J., Friedman-Kien A. E., Brady E. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds. Antimicrob Agents Chemother. 1974 Mar;5(3):318–322. doi: 10.1128/aac.5.3.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Knight A. G. Grenz ray treatment of recurrent herpes simplex. Br J Dermatol. 1972 Feb;86(2):172–174. doi: 10.1111/j.1365-2133.1972.tb16082.x. [DOI] [PubMed] [Google Scholar]
  123. Koprowski H., Jensen F. C., Steplewski Z. Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc Natl Acad Sci U S A. 1967 Jul;58(1):127–133. doi: 10.1073/pnas.58.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Kristensson K., Lycke E., Sjöstrand J. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. 1971;17(1):44–53. doi: 10.1007/BF00684740. [DOI] [PubMed] [Google Scholar]
  125. Kristensson K., Lycke E., Sjöstrand J. Transport of herpes simplex virus in peripheral nerves. Acta Physiol Scand Suppl. 1970;357:13–14. [PubMed] [Google Scholar]
  126. Kristensson K. Morphological studies of the neural spread of herpes simplex virus to the central nervous system. Acta Neuropathol. 1970;16(1):54–63. doi: 10.1007/BF00686964. [DOI] [PubMed] [Google Scholar]
  127. Kurimoto S., Kandor F., Kishida T. [Effect of IDC to viral keratitis]. Nihon Ganka Kiyo. 1969 Jan;20(1):49–52. [PubMed] [Google Scholar]
  128. Laibson P. R., Kibrick S. Recurrence of herpes simplex virus in rabbit eyes: results of a three-year study. Invest Ophthalmol. 1969 Jun;8(3):346–350. [PubMed] [Google Scholar]
  129. Laugier P., Orusco M. Herpès et zonas térébrants et récidivants au cours d'hémopathies (traitées par immunosuppresseurs. J Med Lyon. 1972 Sep 5;53(232):1105–1107. [PubMed] [Google Scholar]
  130. Lederberg E M, Lederberg J. Genetic Studies of Lysogenicity in Escherichia Coli. Genetics. 1953 Jan;38(1):51–64. doi: 10.1093/genetics/38.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Leestma J. E., Bornstein M. B., Sheppard R. D., Feldman L. A. Ultrastructural aspects of herpes simplex virus infection in organized cultures of mammalian nervous tissue. Lab Invest. 1969 Jan;20(1):70–78. [PubMed] [Google Scholar]
  132. Levitt J., Becker Y. The effect of cytosine arabinoside on the replication of herpes simplex virus. Virology. 1967 Jan;31(1):129–134. doi: 10.1016/0042-6822(67)90016-5. [DOI] [PubMed] [Google Scholar]
  133. Lindgren K. M., Douglas R. G., Jr, Couch R. B. Significance of Herpesvirus hominis in respiratory secretions of man. N Engl J Med. 1968 Mar 7;278(10):517–523. doi: 10.1056/NEJM196803072781001. [DOI] [PubMed] [Google Scholar]
  134. Logan W. S., Tindall J. P., Elson M. L. Chronic cutaneous herpes simplex. Arch Dermatol. 1971 Jun;103(6):606–614. [PubMed] [Google Scholar]
  135. Lwoff A. Death and transfiguration of a problem. Bacteriol Rev. 1969 Sep;33(3):390–403. doi: 10.1128/br.33.3.390-403.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Lynch P. G., Longson M. R. Herpes simplex encephalitis. A report of three further cases. Pathol Eur. 1973;8(2):149–161. [PubMed] [Google Scholar]
  137. MOGABGAB W. J. VIRUSES ASSOCIATED WITH UPPER RESPIRATORY ILLNESSES IN ADULTS. Ann Intern Med. 1963 Sep;59:306–322. doi: 10.7326/0003-4819-59-3-306. [DOI] [PubMed] [Google Scholar]
  138. MacCallum F. O. Virus-related mental defect and disorder. Proc R Soc Med. 1972 Jul;65(7):585–587. [PMC free article] [PubMed] [Google Scholar]
  139. Mandal B. K. A survey of acute encephalitis. Public Health. 1972 Jul;86(5):215–224. doi: 10.1016/s0033-3506(72)80050-7. [DOI] [PubMed] [Google Scholar]
  140. Mankad V. N., Gershon A. A., Brunell P. A. Inhibition of oral shedding of herpes simplex virus by cytosine arabinoside. J Infect Dis. 1973 Apr;127(4):442–444. doi: 10.1093/infdis/127.4.442. [DOI] [PubMed] [Google Scholar]
  141. Marin G., Littlefield J. W. Selection of morphologically normal cell lines from polyoma-transformed BHK21/13 hamster fibroblasts. J Virol. 1968 Jan;2(1):69–77. doi: 10.1128/jvi.2.1.69-77.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Marshall W. J. Herpes simplex encephalitis treated with idoxuridine and external decompression. Lancet. 1967 Sep 16;2(7516):579–580. doi: 10.1016/s0140-6736(67)90736-2. [DOI] [PubMed] [Google Scholar]
  143. Masukawa T., Garancis J. C., Rytel M. W., Mattingly R. F. Herpes genitalis virus isolation from human bladder urine. Acta Cytol. 1972 Sep-Oct;16(5):416–428. [PubMed] [Google Scholar]
  144. McCormick D. P. Herpes-simplex virus as a cause of Bell's palsy. Lancet. 1972 Apr 29;1(7757):937–939. doi: 10.1016/s0140-6736(72)91499-7. [DOI] [PubMed] [Google Scholar]
  145. McIndoe W. A., Churchouse M. J. Herpes simplex of the lower genital tract in the female. Aust N Z J Obstet Gynaecol. 1972 Feb;12(1):14–23. doi: 10.1111/j.1479-828x.1972.tb00722.x. [DOI] [PubMed] [Google Scholar]
  146. Melnikoff R. M. Photodynamic inactivation of herpes simplex infections. Calif Med. 1972 Jun;116(6):51–52. [PMC free article] [PubMed] [Google Scholar]
  147. Meyer J. S., Bauer R. B., Rivera-Olmos V. M., Nolan D. C., Lerner A. M. Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol. 1970 Nov;23(5):438–450. doi: 10.1001/archneur.1970.00480290058007. [DOI] [PubMed] [Google Scholar]
  148. Meyers R. L., Pettit T. H. Chemotaxis of polymorphonuclear leukocytes in corneal inflammation: tissue injury in herpes simplex virus infection. Invest Ophthalmol. 1974 Mar;13(3):187–197. [PubMed] [Google Scholar]
  149. Moore C., Wallis C., Melnick J. L., Kuns M. D. Photodynamic treatment of herpes keratitis. Infect Immun. 1972 Feb;5(2):169–171. doi: 10.1128/iai.5.2.169-171.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Mufson M. A., Webb P. A., Kennedy H., Gill V., Chanock R. M. Etiology of upper-respiratory-tract illnesses among civilian adults. JAMA. 1966 Jan 3;195(1):1–7. [PubMed] [Google Scholar]
  151. Munk K., Darai G., Kansteiner V., Penzholz H. Herpesvirus hominis specific antigen in cells of human malignant glioma. Naturwissenschaften. 1972 Sep;59(9):424–424. doi: 10.1007/BF00623143. [DOI] [PubMed] [Google Scholar]
  152. Munk K., Frick T. Effect of poly I:C-induced interferon on herpes virus hominis infection in vitro and in vivo. Z Naturforsch B. 1972 Mar;27(3):220–222. doi: 10.1515/znb-1972-0301. [DOI] [PubMed] [Google Scholar]
  153. Munyon W., Kraiselburd E., Davis D., Zeigel R., Buchsbaum R., Paoletti E. Biochemical transformation of L-cells with ultraviolet-irradiated herpes simplex virus. Fed Proc. 1972 Nov-Dec;31(6):1669–1673. [PubMed] [Google Scholar]
  154. Nahmias A. J., DelBuono I., Schneweis K. E., Gordon D. S., Thies D. Type-specific surface antigens of cells infected with herpes simplex virus (1 and 2). Proc Soc Exp Biol Med. 1971 Oct;138(1):21–27. doi: 10.3181/00379727-138-35824. [DOI] [PubMed] [Google Scholar]
  155. Nahmias A. J., Naib Z. M., Josey W. E. Epidemiological studies relating genital herpetic infection to cervical carcinoma. Cancer Res. 1974 May;34(5):1111–1117. [PubMed] [Google Scholar]
  156. Nahmias A. J., Von Reyn C. F., Josey W. E., Naib Z. M., Hutton R. D. Genital herpes simplex virus infection and gonorrhoea. Association and analogies. Br J Vener Dis. 1973 Jun;49(3):306–309. doi: 10.1136/sti.49.3.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Nash G. Necrotizing tracheobronchitis and bronchopneumonia consistent with herpetic infection. Hum Pathol. 1972 Jun;3(2):283–291. doi: 10.1016/s0046-8177(72)80082-0. [DOI] [PubMed] [Google Scholar]
  158. Nesburn A. B., Cook M. L., Stevens J. G. Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol. 1972 Oct;88(4):412–417. doi: 10.1001/archopht.1972.01000030414012. [DOI] [PubMed] [Google Scholar]
  159. Nesburn A. B., Ziniti P. J. Long-term poly I:C in experimental chronic ocular herpes simplex infection. Am J Ophthalmol. 1971 Oct;72(4):821–826. doi: 10.1016/0002-9394(71)90024-9. [DOI] [PubMed] [Google Scholar]
  160. Netter R., Franceschini P., Chaniot S., Piat A. Traitement local de 32 malades atteints d'herpès cutanéo-muqueux par la rifamycine SV ou la rifampicine. Nouv Presse Med. 1972 Oct 14;1(36):2403–2403. [PubMed] [Google Scholar]
  161. Ng A. B., Reagan J. W., Yen S. S. Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol. 1970 Oct;36(4):645–651. [PubMed] [Google Scholar]
  162. Nii S. Persistent infection with herpes simplex virus in vitro. 1. Establishment and characteristics of persistent herpes simplex virus infection in Earle's L cells. Biken J. 1969 Jun;12(2):45–67. [PubMed] [Google Scholar]
  163. Nii S. Persistent infection with herpes simplex virus in vitro. II. Effect of antibody on the course of herpetic persistency in Earle's L cells. Biken J. 1970 Dec;13(4):339–352. [PubMed] [Google Scholar]
  164. Nonoyama M., Pagano J. S. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol. 1972 Aug 9;238(84):169–171. doi: 10.1038/newbio238169a0. [DOI] [PubMed] [Google Scholar]
  165. Nugent G. R., Chou S. M. Treatment of labial herpes. JAMA. 1973 Apr 2;224(1):132–132. [PubMed] [Google Scholar]
  166. O'Neill F. J., Goldberg R. J., Rapp F. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside. J Gen Virol. 1972 Feb;14(2):189–197. doi: 10.1099/0022-1317-14-2-189. [DOI] [PubMed] [Google Scholar]
  167. O'Neill F. J., Rapp F. Early events required for induction of chromosome abnormalities in human cells by herpes simplex virus. Virology. 1971 Jun;44(3):544–553. doi: 10.1016/0042-6822(71)90368-0. [DOI] [PubMed] [Google Scholar]
  168. O'Neill F. J., Rapp F. Synergistic effect of herpes simplex virus and cytosine arabinoside on human chromosomes. J Virol. 1971 May;7(5):692–695. doi: 10.1128/jvi.7.5.692-695.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Ogino T., Shiman R., Rapp F. Deoxythymidine kinase from rabbit kidney cells infected with herpes simplex virus types 1 and 2. Intervirology. 1973;1(2):80–95. doi: 10.1159/000148835. [DOI] [PubMed] [Google Scholar]
  170. Oh J. O. Enhancement of virus multiplication and interferon production by cortisone in ocular herpesvirus infection. J Immunol. 1970 Jun;104(6):1359–1363. [PubMed] [Google Scholar]
  171. Oh J. O. Sensitivity of Types 1 and 2 Herpesvirus hominis to an Interferon Inducer, Poly I:C. Infect Immun. 1971 Jun;3(6):847–848. doi: 10.1128/iai.3.6.847-848.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Olson L. C., Buescher E. L., Artenstein M. S., Parkman P. D. Herpesvirus infections of the human central nervous system. N Engl J Med. 1967 Dec 14;277(24):1271–1277. doi: 10.1056/NEJM196712142772401. [DOI] [PubMed] [Google Scholar]
  173. Ota W. K., Bang F. B. A continuous study of viruses in the respiratory tract in families of a Calcutta bustee. I. Description of the study area and patterns of virus recovery. Am J Epidemiol. 1972 Apr;95(4):371–383. doi: 10.1093/oxfordjournals.aje.a121406. [DOI] [PubMed] [Google Scholar]
  174. Ota W. K., Bang F. B. A continuous study of viruses in the respiratory tract in families of a Calcutta bustee. II. Family patterns of infection and illness in a crowded environment. Am J Epidemiol. 1972 Apr;95(4):384–391. doi: 10.1093/oxfordjournals.aje.a121407. [DOI] [PubMed] [Google Scholar]
  175. PAINE T. F., Jr LATENT HERPES SIMPLEX INFECTION IN MAN. Bacteriol Rev. 1964 Dec;28:472–479. doi: 10.1128/br.28.4.472-479.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Palmer E. L., Feorino P. M., Martin M. L. Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer. J Infect Dis. 1972 Aug;126(2):186–188. doi: 10.1093/infdis/126.2.186. [DOI] [PubMed] [Google Scholar]
  177. Park J. H., Baron S. Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science. 1968 Nov 15;162(3855):811–813. doi: 10.1126/science.162.3855.811. [DOI] [PubMed] [Google Scholar]
  178. Pavan-Langston D., Dohlman C. H. A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol. 1972 Jul;74(1):81–88. doi: 10.1016/0002-9394(72)91130-0. [DOI] [PubMed] [Google Scholar]
  179. Person D. A., Sheridan P. J., Herrmann E. C. Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine. Infect Immun. 1970 Dec;2(6):815–820. doi: 10.1128/iai.2.6.815-820.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Plummer G., Coleman P. L., Henson D. Chronic infection of the rabbit central nervous system by a slowly growing equine herpesvirus. Infect Immun. 1972 Feb;5(2):172–175. doi: 10.1128/iai.5.2.172-175.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Plummer G., Hollingsworth D. C., Phuangsab A., Bowling C. P. Chronic infections by herpes simplex viruses and by the horse and cat herpesviruses. Infect Immun. 1970 Apr;1(4):351–355. doi: 10.1128/iai.1.4.351-355.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Pokorny A. D., Rawls W. E., Adam E., Mefferd R. B., Jr Depression, psychopathy, and herpesvirus type I antibodies. Lack of relationship. Arch Gen Psychiatry. 1973 Dec;29(6):820–822. doi: 10.1001/archpsyc.1973.04200060092014. [DOI] [PubMed] [Google Scholar]
  183. Pollikoff R., Cannavale P., Dixon P. Herpes simplex virus infection in rabbit eye. Arch Ophthalmol. 1972 Jul;88(1):52–57. doi: 10.1001/archopht.1972.01000030054012. [DOI] [PubMed] [Google Scholar]
  184. RAPP F. INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES. J Immunol. 1964 Oct;93:643–648. [PubMed] [Google Scholar]
  185. Rabin E. R., Jenson A. B., Melnick J. L. Herpes simplex virus in mice: electron microscopy of neural spread. Science. 1968 Oct 4;162(3849):126–127. doi: 10.1126/science.162.3849.126. [DOI] [PubMed] [Google Scholar]
  186. Rabson A. S., Tyrrell S. A., Legallais F. Y. An inhibitor of herpesvirus hominis in extracts of cultures of Burkitt's lymphoma cells. Proc Soc Exp Biol Med. 1971 May;137(1):264–267. doi: 10.3181/00379727-137-35557. [DOI] [PubMed] [Google Scholar]
  187. Rapp F., Duff R. Transformation of hamster embryo fibroblasts by herpes simplex viruses type 1 and type 2. Cancer Res. 1973 Jun;33(6):1527–1534. [PubMed] [Google Scholar]
  188. Rapp F., Li J. L., Jerkofsky M. Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation. Virology. 1973 Oct;55(2):339–346. doi: 10.1016/0042-6822(73)90173-6. [DOI] [PubMed] [Google Scholar]
  189. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  190. Rawls W. E., Gardner H. L., Flanders R. W., Lowry S. P., Kaufman R. H., Melnick J. L. Genital herpes in two social groups. Am J Obstet Gynecol. 1971 Jul 1;110(5):682–689. doi: 10.1016/0002-9378(71)90254-7. [DOI] [PubMed] [Google Scholar]
  191. Rawls W. E., Laurel D., Melnick J. L., Glicksman J. M., Kaufman R. H. A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol. 1968 May;87(3):647–655. doi: 10.1093/oxfordjournals.aje.a120855. [DOI] [PubMed] [Google Scholar]
  192. Rimon R., Halonen P., Anttinen E., Evola K. Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Dis Nerv Syst. 1971 Dec;32(12):822–824. [PubMed] [Google Scholar]
  193. Robinson T. W., Dover J. R. Experimental zosteriform herpes simplex virus infection in mouse skin. Br J Dermatol. 1972 Jan;86(1):40–48. doi: 10.1111/j.1365-2133.1972.tb01889.x. [DOI] [PubMed] [Google Scholar]
  194. Roizman B., Frenkel N. The transcription and state of herpes simplex virus DNA in productive infection and in human cervical cancer tissue. Cancer Res. 1973 Jun;33(6):1402–1416. [PubMed] [Google Scholar]
  195. Rosenberg G. L., Farber P. A., Notkins A. L. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A. 1972 Mar;69(3):756–760. doi: 10.1073/pnas.69.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Rosenberg G. L., Wohlenberg C., Nahmias A. J., Notkins A. L. Differentiation of type 1 and type 2 herpes simplex virus by in vitro stimulation of immune lymphocytes. J Immunol. 1972 Aug;109(2):413–414. [PubMed] [Google Scholar]
  197. Rosenblum H. Recurrent viral infection: an annotation. Del Med J. 1971 Sep;43(9):257–258. [PubMed] [Google Scholar]
  198. Ross C. A. Herpes simplex and temporal lobe epilepsy. Br Med J. 1972 Jul 8;3(5818):112–112. doi: 10.1136/bmj.3.5818.112-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Rowe W. P., Hartley J. W., Lander M. R., Pugh W. E., Teich N. Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology. 1971 Dec;46(3):866–876. doi: 10.1016/0042-6822(71)90087-0. [DOI] [PubMed] [Google Scholar]
  200. Royston I., Aurelian L. Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma. Proc Natl Acad Sci U S A. 1970 Sep;67(1):204–212. doi: 10.1073/pnas.67.1.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Ruiz-Gómez J., Carranza-Acevedo J. Anticuerpos neutralizantes contra el virus del herpes siimple en enfermos mentales. Arch Invest Med (Mex) 1971;2(3):467–470. [PubMed] [Google Scholar]
  202. Rustigian R., Smulow J. B., Tye M., Gibson W. A., Shindell E. Studies on latent infection of skin and oral mucosa in individuals with recurrent herpes simplex. J Invest Dermatol. 1966 Sep;47(3):218–221. doi: 10.1038/jid.1966.132. [DOI] [PubMed] [Google Scholar]
  203. SCHMIDT J. R., RASMUSSEN A. F., Jr Activation of latent herpes simplex encephalitis by chemical means. J Infect Dis. 1960 Mar-Apr;106:154–158. doi: 10.1093/infdis/106.2.154. [DOI] [PubMed] [Google Scholar]
  204. SCOTT T. F. M. Epidemiology of herpetic infections. Am J Ophthalmol. 1957 Apr;43(4 Pt 2):134–147. doi: 10.1016/0002-9394(57)91496-4. [DOI] [PubMed] [Google Scholar]
  205. STICH H. F., HSU T. C., RAPP F. VIRUSES AND MAMMALIAN CHROMOSOMES. I. LOCALIZATION OF CHROMOSOME ABERRATIONS AFTER INFECTION WITH HERPES SIMPLEX VIRUS. Virology. 1964 Apr;22:439–445. doi: 10.1016/0042-6822(64)90064-9. [DOI] [PubMed] [Google Scholar]
  206. Sabin A. B., Tarro G. Herpes simplex and herpes genitalis viruses in etiology of some human cancers. Proc Natl Acad Sci U S A. 1973 Nov;70(11):3225–3229. doi: 10.1073/pnas.70.11.3225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Sambrook J., Westphal H., Srinivasan P. R., Dulbecco R. The integrated state of viral DNA in SV40-transformed cells. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1288–1295. doi: 10.1073/pnas.60.4.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Sawicki L., Chowchuvech E., Weissenbacher M., Baron S., Galin M. A. Pathogenetic studies of herpes simplex virus infection of the rabbit eye. Proc Soc Exp Biol Med. 1973 Nov;144(2):705–709. doi: 10.3181/00379727-144-37666. [DOI] [PubMed] [Google Scholar]
  209. Schwartz J., Elizan T. S. Chronic herpes simplex virus infection. Initiation in hamsters upon implantation of infected nonpermissive glial cells. Arch Neurol. 1973 Apr;28(4):224–230. doi: 10.1001/archneur.1973.00490220032003. [DOI] [PubMed] [Google Scholar]
  210. Severin M. J., White R. J. The neural transmission of herpes simplex virus in mice. Light and electron microscopic findings. Am J Pathol. 1968 Dec;53(6):1009–1020. [PMC free article] [PubMed] [Google Scholar]
  211. Sheldrick P., Laithier M., Lando D., Ryhiner M. L. Infectious DNA from herpes simplex virus: infectivity of double-stranded and single-stranded molecules. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3621–3625. doi: 10.1073/pnas.70.12.3621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Shipkowitz N. L., Bower R. R., Appell R. N., Nordeen C. W., Overby L. R., Roderick W. R., Schleicher J. B., Von Esch A. M. Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol. 1973 Sep;26(3):264–267. doi: 10.1128/am.26.3.264-267.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Shope T. C., Klein-Robbenhaar J., Miller G. Fatal encephalitis due to Herpesvirus hominis: use of intact brain cells for isolation of virus. J Infect Dis. 1972 May;125(5):542–544. doi: 10.1093/infdis/125.5.542. [DOI] [PubMed] [Google Scholar]
  214. Snyderman R., Wohlenberg C., Notkins A. L. Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus. J Infect Dis. 1972 Aug;126(2):207–209. doi: 10.1093/infdis/126.2.207. [DOI] [PubMed] [Google Scholar]
  215. Stalder H., Oxman M. N., Dawson D. M., Levin M. J. Herpes simplex meningitis: isolation of herpes simplex virus type 2 from cerebrospinal fluid. N Engl J Med. 1973 Dec 13;289(24):1296–1298. doi: 10.1056/NEJM197312132892409. [DOI] [PubMed] [Google Scholar]
  216. Stevens J. G., Cook M. L. Latent herpes simplex virus in spinal ganglia of mice. Science. 1971 Aug 27;173(3999):843–845. doi: 10.1126/science.173.3999.843. [DOI] [PubMed] [Google Scholar]
  217. Stevens J. G., Cook M. L. Latent infections induced by herpes simplex viruses. Cancer Res. 1973 Jun;33(6):1399–1401. [PubMed] [Google Scholar]
  218. Stevens J. G., Cook M. L. Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction. J Exp Med. 1971 Jan 1;133(1):19–38. doi: 10.1084/jem.133.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Stevens J. G., Nesburn A. B., Cook M. L. Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nat New Biol. 1972 Feb 16;235(59):216–217. doi: 10.1038/newbio235216a0. [DOI] [PubMed] [Google Scholar]
  220. Tkach R. M., Maevskaia T. M. Lechenie gerpeticheskoi vaktsinoi bol'ykh retsidiviriushchim gerpesom. Vestn Dermatol Venerol. 1966 Mar;40(3):69–71. [PubMed] [Google Scholar]
  221. Tokumaru T. A possible role of gamma-A-immunoglobulin in herpes simplex virus infection in man. J Immunol. 1966 Aug;97(2):248–259. [PubMed] [Google Scholar]
  222. Tokumaru T., Avitabile A. Suppression of herpes simplex virus infection by antimitotic substances in the rabbit cornea. Proc Soc Exp Biol Med. 1971 May;137(1):29–34. doi: 10.3181/00379727-137-35505. [DOI] [PubMed] [Google Scholar]
  223. Underwood G. E., Nichol F. R. Clinical evaluation of kethoxal against cutaneous herpes simplex. Appl Microbiol. 1971 Oct;22(4):588–592. doi: 10.1128/am.22.4.588-592.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Underwood P. A. Herpes simplex infection of HEp-2 and L-929 cells. 2. The kinetics of virus multiplication and cell lysis, and the measurement of interferon production. Microbios. 1972 May-Jun;5(19):167–176. [PubMed] [Google Scholar]
  225. Upton A. R. Herpes encephalitis. Br Med J. 1972 Apr 22;2(5807):226–227. doi: 10.1136/bmj.2.5807.226-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. WOLLMAN E. L. Sur le determinisme génetique de la lysogénie. Ann Inst Pasteur (Paris) 1953 Jan;84(1):281–293. [PubMed] [Google Scholar]
  227. WYBURN-MASON R. Malignant change following herpes simplex. Br Med J. 1957 Sep 14;2(5045):615–616. doi: 10.1136/bmj.2.5045.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Wallis C., Melnick J. L. Herpesvirus neutralization: the role of complement. J Immunol. 1971 Nov;107(5):1235–1242. [PubMed] [Google Scholar]
  229. Weissenbacher M., Chowchuvech E., Schmunis G., Sawicki L., Galin M. A. Sensitivity of human conjunctival tissue cultures to adenovirus 8, herpes simplex and vaccinia viruses. Induction of resistance by an interferon inducer. Proc Soc Exp Biol Med. 1973 Mar;142(3):997–1002. doi: 10.3181/00379727-142-37161. [DOI] [PubMed] [Google Scholar]
  230. Wellings P. C., Awdry P. N., Bors F. H., Jones B. R., Brown D. C., Kaufman H. E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1972 Jun;73(6):932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]
  231. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Yang J. P., Wentworth B. B. Study of immune cytotoxicity with Herpesvirus hominis infected cells. Proc Soc Exp Biol Med. 1972 Dec;141(3):759–764. doi: 10.3181/00379727-141-36866. [DOI] [PubMed] [Google Scholar]
  233. Young A. W., Jr Herpes genitalis. Med Clin North Am. 1972 Sep;56(5):1175–1192. doi: 10.1016/s0025-7125(16)32343-4. [DOI] [PubMed] [Google Scholar]
  234. Zur Hausen H., Schulte-Holthausen H. Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells. Nature. 1970 Jul 18;227(5255):245–248. doi: 10.1038/227245a0. [DOI] [PubMed] [Google Scholar]

Articles from Bacteriological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES